Conditions: Generalized Anxiety Disorder
Keywords: Generalized Anxiety Disorder GAD Antidepressant Anxiolytic
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 30
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the effect of escitalopram after 8 weeks of treatment in patients with Generalized Anxiety Disorder (GAD), to evaluate proportion of patients who respond to escitalopram during the treatment period, and to evaluate safety of escitalopram.

Detailed description:
The study will be performed in Russia, as an open-label, uncontrolled, one arm trial. The patients will receive escitalopram for 8 weeks. Start and maintenance dosages as well as dose titration will be left to the investigators' decision (5 to 20 mg/day), in accordance with the national Summary of Products Characteristics (SPC).

Arms:
arm 1: None

Interventions: intervention 1: Escitalopram
Intervention descriptions: intervention 1: Flexible-dosed (5 to 20 mg Oral Tablets Daily)

Protocol document: